RayzeBio aims to improve clinical benefit by efficiently developing innovative tumor-targeted small molecule medicines that harness the power of radioisotopes.
Company Name
RayzeBio (RYZB)Company Website
http://rayzebio.com/Location
San Diego, CAInvestment Stage
IPO September 2023Connected News
- RayzeBio Secures $108 Million Series C Financing to Drive Forward Its Pipeline of Targeted Radiopharmaceuticals for Cancer
- RayzeBio Completes $105M Series B Financing to Advance Targeted Radiopharmaceuticals for Cancer
- RayzeBio Launches with $45 Million Series A to Advance Portfolio of Targeted Radiopharmaceuticals for Cancer Therapeutics